These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29269439)
21. [Chemotherapy for metastatic colorectal cancer]. Iwasa S; Shimada Y Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899 [TBL] [Abstract][Full Text] [Related]
22. Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils. Seignez C; Martin A; Rollet CE; Racoeur C; Scagliarini A; Jeannin JF; Bettaieb A; Paul C Oncotarget; 2014 Nov; 5(22):11442-51. PubMed ID: 25347345 [TBL] [Abstract][Full Text] [Related]
23. The treatment of colorectal carcinoma: standard chemotherapy and beyond. Eng C; Abbruzzese JL Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242 [TBL] [Abstract][Full Text] [Related]
24. Current directions in chemotherapy for colorectal cancer. Inoue Y; Miki C; Kusunoki M J Gastroenterol; 2006 Sep; 41(9):821-31. PubMed ID: 17048045 [No Abstract] [Full Text] [Related]
26. [Experience with the use of immunochemotherapy in stage-IV colorectal cancer]. Grinev MV; Abdusamatov FKh; Pivovarova LP; Golubeva AV Vestn Khir Im I I Grek; 1997; 156(3):68-72. PubMed ID: 9324850 [No Abstract] [Full Text] [Related]
27. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience. Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353 [TBL] [Abstract][Full Text] [Related]
28. [Oxaliplatinum in combination with 5-FU/FA in first-line chemotherapy of metastatic colorectal cancer: a new era in therapeutic strategy]. Tumori; 2000; 86(2):A1-4. PubMed ID: 10855861 [No Abstract] [Full Text] [Related]
29. Integration of novel agents in the treatment of colorectal cancer. Iqbal S; Lenz HJ Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512 [TBL] [Abstract][Full Text] [Related]
30. Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity. Maeda K; Hazama S; Tokuno K; Kan S; Maeda Y; Watanabe Y; Kamei R; Shindo Y; Maeda N; Yoshimura K; Yoshino S; Oka M Anticancer Res; 2011 Dec; 31(12):4569-74. PubMed ID: 22199332 [TBL] [Abstract][Full Text] [Related]
31. [What is confirmed in chemo- and immunotherapy of solid tumors. Standard protocols, studies and new developments]. Link KH; Beger HG Chirurg; 1992 May; 63(5):401-9. PubMed ID: 1606855 [TBL] [Abstract][Full Text] [Related]
32. [Response criteria for malignant melanoma: RECIST and irRC]. Spiro J; Maintz D; Persigehl T Radiologe; 2015 Feb; 55(2):127-35. PubMed ID: 25637198 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemotherapy for colorectal cancer. Kerr DJ; Gray R Br J Hosp Med; 1996 Mar 6-19; 55(5):259-62. PubMed ID: 8777517 [No Abstract] [Full Text] [Related]
37. Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scans. Monteil J; Mahmoudi N; Leobon S; Roudaut PY; El Badaoui A; Verbeke S; Venat-Bouvet L; Martin J; Le Brun-Ly V; Lavau-Denes S; Maubon A; Bouillet P; Pouquet M; Vandroux JC; Tubiana-Mathieu N Anticancer Res; 2009 Jul; 29(7):2563-8. PubMed ID: 19596929 [TBL] [Abstract][Full Text] [Related]
38. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer. Chu E Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405 [No Abstract] [Full Text] [Related]